58730-43-1 Usage
Uses
Used in Organic Synthesis:
2-(3-aminophenyl)-N,N-dimethylacetamide(SALTDATA: FREE) is used as a reagent in organic synthesis for the creation of various chemical compounds. Its unique structure allows it to participate in a range of chemical reactions, facilitating the synthesis of new molecules with potential applications in various fields.
Used in Chemical Research:
In the realm of chemical research, 2-(3-aminophenyl)-N,N-dimethylacetamide(SALTDATA: FREE) serves as a valuable reagent. It aids scientists in understanding the properties and behavior of different chemical systems, contributing to the advancement of knowledge in chemistry.
Used in Pharmaceutical Industry:
2-(3-aminophenyl)-N,N-dimethylacetamide(SALTDATA: FREE) is used as a building block in the development of pharmaceutical compounds. Its unique structure can be incorporated into drug molecules to enhance their efficacy, selectivity, or stability, making it a promising candidate for the design of new therapeutic agents.
Used in Materials Science:
In materials science, 2-(3-aminophenyl)-N,N-dimethylacetamide(SALTDATA: FREE) is utilized for the development of novel materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with improved characteristics, such as enhanced stability, reactivity, or selectivity, depending on the application.
Check Digit Verification of cas no
The CAS Registry Mumber 58730-43-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,7,3 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 58730-43:
(7*5)+(6*8)+(5*7)+(4*3)+(3*0)+(2*4)+(1*3)=141
141 % 10 = 1
So 58730-43-1 is a valid CAS Registry Number.
58730-43-1Relevant articles and documents
SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE
-
Paragraph 00165; 00168; 00170, (2020/07/05)
Disclosed are compounds and pharmaceutically acceptable salts and stereoisomers thereof that may cause degradation of various proteins e.g., IKZF2 (Helios). Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds to treat diseases and disorders characterized or mediated by aberrant protein activity.
HETEROCYCLYL COMPOUNDS AS MEK INHIBITORS
-
Paragraph 0264-0265, (2015/05/26)
The present disclosure is related to heteroaryl compounds as MEK inhibitors. These compounds include heteroaryl compounds of formula I, their pharmaceutically acceptable salts, combinations with suitable medicament and pharmaceutical compositions thereof.
HETEROCYCLYL COMPOUNDS AS MEK INHIBITORS
-
Page/Page column 52, (2013/09/26)
The present disclosure is related to heteroaryl compounds as MEK inhibitors. These compounds include heteroaryl compounds of Formula (I), their pharmaceutically acceptable salts, combinations with suitable medicament and pharmaceutical compositions thereo